S. Alqahtani Et Al. , "Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin," JOURNAL OF VIRAL HEPATITIS , vol.24, no.4, pp.280-286, 2017
Alqahtani, S. Et Al. 2017. Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin. JOURNAL OF VIRAL HEPATITIS , vol.24, no.4 , 280-286.
Alqahtani, S., Ozaras, R., Isakov, V., Wyles, D., Ferenci, P., Feld, J. J., ... Calinas, F.(2017). Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin. JOURNAL OF VIRAL HEPATITIS , vol.24, no.4, 280-286.
Alqahtani, S. Et Al. "Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin," JOURNAL OF VIRAL HEPATITIS , vol.24, no.4, 280-286, 2017
Alqahtani, S. Et Al. "Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin." JOURNAL OF VIRAL HEPATITIS , vol.24, no.4, pp.280-286, 2017
Alqahtani, S. Et Al. (2017) . "Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin." JOURNAL OF VIRAL HEPATITIS , vol.24, no.4, pp.280-286.
@article{article, author={S. Alqahtani Et Al. }, title={Time to viral suppression is not related to achievement of SVR12 in HCV GT1-infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin}, journal={JOURNAL OF VIRAL HEPATITIS}, year=2017, pages={280-286} }